Delivery Order SPE2DB20D1100-SPE2DB24FD0N3

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,143.51 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lacosamide 10 mg/ml solution, a prescription medication, to support federal healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,571.84, is for the delivery of Lacosamide 10 mg/ml solution in 200 ml containers. The contract is a firm fixed-price delivery order with a period of performance through January 16, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,118.64, is for the delivery of Lacosamide 10 mg/ml solution in 200 ml containers. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $7,970.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200 ml containers. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Lacosamide 10 mg/ml solution in 200 ml containers. The fixed-price contract has a ceiling value of $2,453.78 and an ultimate completion date of August 20, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical supplies and prescription drugs to support various government agencies and healthcare programs, including the...
This is a $1,464.96 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of lacosamide 10 mg/ml solution in 200 ml bottles. The contract does not have a set-aside designation and has an ultimate completion date of September 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription drug products to support federal healthcare programs and facilities. The award is part of a larger...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,177.78 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Lacosamide 10 mg/ml solution in 200ml bottles. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
This federal contract award, valued at $3,996.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. It has an ultimate completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $4,542.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200 ml quantities, a pharmaceutical product used for medical treatment. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,190.52 Firm Fixed Price delivery order is for the pharmaceutical product Lacosamide 200 mg Tablet 60s. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA valued at $999,999,999, running through November 2026. This IDC...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD0N3
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lacosamide 200 mg/20 ml vials. The contract has a firm fixed price of $1,946.95 and an ultimate completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/31/24, 9:18 AM